Related Experiment Video

Updated: Apr 18, 2026

Development of Human Renal Tubular Epithelial Cell Primary Cultures in Monolayers and Three-Dimensional Conditions
06:32

Development of Human Renal Tubular Epithelial Cell Primary Cultures in Monolayers and Three-Dimensional Conditions

Published on: June 13, 2025

677

Cadmium transporters in the kidney and cadmium-induced nephrotoxicity

Hong Yang1, Yan Shu2

  • 1Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland at Baltimore, Baltimore, MD 21201, USA. hong.yang@umaryland.edu.

International Journal of Molecular Sciences
|January 14, 2015
PubMed

Insights

This review details how the environmental pollutant cadmium enters kidney cells and causes toxicity. It highlights the role of transporter proteins in cadmium-induced kidney damage.

Area of Science:

  • Environmental toxicology
  • Renal physiology
  • Molecular biology

Background:

  • Cadmium is an environmental pollutant with known toxicity to multiple organs.
  • The kidney is a primary target organ for cadmium toxicity.
  • Understanding cadmium's cellular entry and toxic mechanisms in the kidney is crucial.

Purpose of the Study:

  • To review the mechanisms of cadmium transport into renal epithelial cells.
  • To elucidate the role of specific transporter proteins in cadmium nephrotoxicity.
  • To summarize recent advancements in understanding cadmium-induced kidney damage.

Main Methods:

  • Literature review of studies on cadmium transport and nephrotoxicity.
  • Analysis of research on renal transporter proteins involved in cadmium uptake.
  • Synthesis of findings on the molecular mechanisms of cadmium toxicity in the kidney.

Main Results:

  • Cadmium enters renal cells via various transport pathways.
  • Specific transporter proteins play a significant role in cadmium accumulation in the kidney.
  • These transporters contribute to the development of cadmium-induced nephrotoxicity.

Conclusions:

  • The transport of cadmium into kidney cells is mediated by specific transporter proteins.
  • These transporters are key players in the pathogenesis of cadmium nephrotoxicity.
  • Further research into these mechanisms can inform strategies for preventing kidney damage from cadmium exposure.

More Related Videos

Cytosolic Calcium Measurements in Renal Epithelial Cells by Flow Cytometry10:24

Cytosolic Calcium Measurements in Renal Epithelial Cells by Flow Cytometry

Published on: October 28, 2014

15.9K
An Anaerobic Biosensor Assay for the Detection of Mercury and Cadmium09:33

An Anaerobic Biosensor Assay for the Detection of Mercury and Cadmium

Published on: December 17, 2018

10.9K

Related Concept Videos

Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
3.8K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
525
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.3K
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
214
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
1.2K